Intensive care by osteopathy for victims of road traffic accidents (RTA) (AIVIO: Aide Intensive aux Victimes d?Accident de la Voie Publique (AVP) par Ostéopathie)

Intensive care by osteopathy for victims of road traffic accidents (RTA) (AIVIO: Aide Intensive aux Victimes d?Accident de la Voie Publique (AVP) par Ostéopathie): a single centre, pilot, prospective, randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN46623132

Enrollment

Registered

2011-05-19

Start date

2007-03-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-traumatic stress disorder Mental and Behavioural Disorders Post-traumatic stress disorder

Interventions

Treatment group 1: trauma victims (11 people), two men aged between 49 and 51 and nine women aged between 25 and 56. Treatment involving 10 sessions of functional osteopathy, of one hour each, spaced

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Recent road traffic accident victims 2. Positive test for PTSD (PCLS>44) over 6 months after the RTA 3. Accept saliva tests: 2 daily saliva samples, one on waking and the other 30 minutes after the first, on an empty stomach and without having smoked or brushed teeth. Over a period of 28 days before and after treatment

Exclusion criteria

Exclusion criteria: 1. People under 18 years of age 2. People under pretraumatic corticotherapy 3. People whose alcohol consumption regularly exceeds two glasses for women or three glasses for men 4. People who did not provide the saliva samples

Design outcomes

Primary

Measure	Time frame
1. Post-traumatic Stress Disorder Checklist Scale (PCLS) 2. Salivary cortisol (IBL - AMERICA Salivary Cortisol HS ELISA Kit, a solid phase enzyme-linked immunosorbent assay based on the principle of competitive binding), measured twice a day for the 28 days before and after the treatment	—

Secondary

Measure	Time frame
1. Quality of life (Medical Outcome Survey SF-36) meassured at each session 2. Pain: EVA and the item bodily pain (MOS SF-36) measured at each session 3. Heart rate measured at each session 4. Dissociation (Dissociative Experience Scale - DES) measured once before and once after the treatment 5. Depression (Beck depression Inventory 21) measured once before and once after the treatment 6. Non traumatic anxiety disorders (phobic disorders, panic attacks, generalized anxiety scale - PPGA) measured once before and once after the treatment 7. Alexithymia (Bermond and Vorst Alexithymia Questionnaire- BVAQ) measured once before and once after the treatment	—

Measure

Time frame

1. Quality of life (Medical Outcome Survey SF-36) meassured at each session 2. Pain: EVA and the item bodily pain (MOS SF-36) measured at each session 3. Heart rate measured at each session 4. Dissociation (Dissociative Experience Scale - DES) measured once before and once after the treatment 5. Depression (Beck depression Inventory 21) measured once before and once after the treatment 6. Non traumatic anxiety disorders (phobic disorders, panic attacks, generalized anxiety scale - PPGA) measured once before and once after the treatment 7. Alexithymia (Bermond and Vorst Alexithymia Questionnaire- BVAQ) measured once before and once after the treatment

—

Countries

Belgium

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026